Integrated Quantitative Investments LLC Takes $377,000 Position in Solventum Co. (NYSE:SOLV)

Integrated Quantitative Investments LLC purchased a new position in shares of Solventum Co. (NYSE:SOLV - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 5,700 shares of the company's stock, valued at approximately $377,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Modus Advisors LLC bought a new stake in shares of Solventum during the 4th quarter valued at approximately $25,000. Stonebridge Financial Group LLC acquired a new stake in shares of Solventum during the 4th quarter valued at $26,000. Crews Bank & Trust bought a new stake in Solventum during the 4th quarter worth $32,000. Synergy Asset Management LLC bought a new position in Solventum in the fourth quarter valued at about $35,000. Finally, Spire Wealth Management acquired a new stake in shares of Solventum during the fourth quarter valued at about $37,000.

Analysts Set New Price Targets

Several equities analysts have issued reports on SOLV shares. Mizuho upped their price target on shares of Solventum from $70.00 to $82.00 and gave the company a "neutral" rating in a research report on Monday, March 3rd. Morgan Stanley lifted their target price on Solventum from $73.00 to $80.00 and gave the company an "equal weight" rating in a research report on Wednesday, March 5th. Wells Fargo & Company lifted their target price on shares of Solventum from $73.00 to $75.00 and gave the stock an "equal weight" rating in a research report on Friday, February 28th. Piper Sandler increased their price target on Solventum from $75.00 to $84.00 and gave the company a "neutral" rating in a research report on Friday, February 28th. Finally, Bank of America boosted their price objective on Solventum from $80.00 to $85.00 and gave the stock a "neutral" rating in a research report on Wednesday, February 26th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and one has given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $79.86.

Solventum Price Performance

Shares of SOLV traded down $3.58 during trading hours on Thursday, reaching $65.00. 390,268 shares of the company's stock traded hands, compared to its average volume of 1,191,877. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45. The firm's 50 day simple moving average is $74.52 and its 200-day simple moving average is $71.75. The stock has a market cap of $11.24 billion and a PE ratio of 23.64. Solventum Co. has a 12 month low of $47.16 and a 12 month high of $85.92.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.